Seguridad de los tratamientos antirreumáticos en la paciente gestante

In recent years, there has been a change in attitude concerning the use of antirheumatic drugs during pregnancy. Ideally, they should be suspended before pregnancy, however, in certain cases it may be necessary to use them to protect mother's health and ensure a correct pregnancy delivery. The most commonly used antirheumatic drugs in pregnancy have been reviewed. Results show that some of them can be taken during pregnancy with a low risk of toxicity, but others should not be administered in this period because of fetal toxicity. Regarding biological therapies in rheumatic diseases, recent studies show that TNF blockers could be continued during the first months of pregnancy.